Voretigene neparvovec

Leave a Comment / Gene therapy, Transhumanism / By

Voretigene neparvovec ( Luxturna ) is a novel gene therapy for the treatment of Leber’s congenital amaurosis . It was developed by Spark Therapeutics and Children’s Hospital of Philadelphia . [1] [2] It is the first in vivo gene therapy approved by the FDA. [3]

Leber’s congenital amaurosis, or biallelic RPE65- mediated inherited retinal disease, is an inherited progressive progressive blindness. Voretigene is the first treatment for this condition. [4]The gene therapy is not a cure for the condition, but rather improves vision in those treated. [5] It is given as an subretinal injection.

The price of the treatment has not been announced, but it is expected to cost around $ 1 million. [3] [6]

Development

Voretigene neparvovec is an AAV2 vector containing human RPE65 cDNA with a modified Kozak sequence . The virus is grown in HEK 293 cells and purified for administration. [7]

It was granted orphan drug status for Leber congenital amaurosis and retinitis pigmentosa . [8] [ better source needed ] A biologics license application was submitted to the FDA in July 2017 with Priority Review . [4] Phase III clinical trial results were published in August 2017. [9] On October 12, 2017, a key advisory panel to the Food and Drug Administration (FDA) , composed of 16 experts, unanimously recommended approval of the treatment. [10] The US FDA approved the drug on December 19, 2017. With the approval, Spark Therapeutics received apediatric disease priority review voucher . [11]

References

  1. Jump up^ “Spark’s gene therapy for blindness is racing to a historic date with the FDA” . Statnews.com . October 9, 2017 . Retrieved 9 October 2017 .
  2. Jump up^ Clarke, Reuters, Toni. “Gene Therapy for Blindness Initially Effective Appears, US Says FDA” . Scientific American . Retrieved 2017-10-12 .
  3. ^ Jump up to:a b “First Gene Therapy For Inherited Disease Gets FDA Approval” . NPR.org . Dec 19, 2017.
  4. ^ Jump up to:a b “Press Release – Investors & Media – Spark Therapeutics” . Ir.sparktx.com . Retrieved 9 October 2017 .
  5. Jump up^ McGinley, Laurie (19 December 2017). “FDA approves first gene therapy for an inherited disease” . Washington Post .
  6. Jump up^ “The First FDA-Approved Gene Therapy Can Cure a Type of Blindness-But May Cost $ 1 Million” . Fortune .
  7. Jump up^ Russell, Stephen; Bennett, Jean; Wellman, Jennifer A .; Chung, Daniel C .; Yu, Zi-Fan; Tillman, Amy; Wittes, Janet; Pappas, Julie; Elci, Okan (2017-08-26). “Efficacy and safety of neparvovec voretigene (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomized, controlled, open-label, phase 3 trial . ” The Lancet . 390 (10097): 849-860. doi : 10.1016 / S0140-6736 (17) 31868-8 . ISSN  0140-6736 . PMID  28712537 .
  8. Jump up^ “Voretigene neparvovec – Spark Therapeutics – AdisInsight” . adisinsight.springer.com .
  9. Jump up^ Lee, Helena; Lotery, Andrew (26 August 2017). “Gene therapy for RPE65-mediated inherited retinal dystrophy complete phase 3” . The Lancet . 390(10097): 823-824. doi : 10.1016 / S0140-6736 (17) 31622-7 . PMID  28712536 . Retrieved 9 October 2017 – via www.thelancet.com.
  10. Jump up^ “Landmark Therapy to Treat Blindness Gets One Step Closer to FDA Approval” . Bloomberg.com . 2017-10-12 . Retrieved 2017-10-12 .
  11. Jump up^ “Spark grabs FDA nod for Luxturna, a breakthrough gene therapy . www.fiercepharma.com .

Related posts:

  1. Gene therapy Gene therapy is the therapeutic delivery of nucleic acid in a patient’s cells as a drug to treat disease. [1] The first attempt at human-modifying DNA Was Performed in 1980 by Martin Cline , drank the first successful nuclear gene transfer in humans, approved by the National Institutes of Health , Was Performed in May 1989. [2] The first therapeutic use of gene transfer as...
  2. Gene therapy of the human retina Retinal gene therapy holds great promise in treating different forms of non-inherited and inherited blindness ....
  3. Gene therapy for color blindness Gene therapy for color blindness is an experimental gene therapy aiming to convert congenitally colorblinds to trichromats by introducing a photopigment gene that they lack. Though partial color blindness is considered to be a disadvantage, it is a condition that affects many people, particularly males . Complete color blindness, or achromatopsia , is very rare but more severe. While never shown in humans, animal studies have...
  4. Gene therapy for osteoarthritis Gene transfer strategies for medical management of osteoarthritis have attracted the attention of scientists to the complex pathology of this chronic disease. Unlike other pharmacological treatments, gene therapy targets the disease process rather than the symptoms. [1]...
  5. Designer baby A designer is a human embryo that has been genetically modified , usually following guidelines set by the parent or scientist, to produce desirable traits. This is done using various methods, such as gene therapy or Preimplantation genetic diagnosis (PGD). This technology is the subject of ethical debate, bringing up the concept of genetically modified “superhumans” to replace modern humans....
  6. Tisagenlecleucel Tisagenlecleucel , marketed as Kymriah , is a treatment for B-cell acute lymphoblastic leukemia which uses the body’s own cells to fight cancer ( adoptive cell transfer )....
  7. Gene therapy in Parkinson’s disease Gene therapy in Parkinson’s disease is a specific neurotransmitter ( dopamine ), protect the neural system, or the modification of genes that are related to the disease. Then these cells are transplanted to a patient with the disease. There are different kinds of treatments that focus on reducing the symptoms of the disease but there...
  8. Antisense therapy Antisense therapy is a form of treatment for genetic disorders or infections. When the genetic sequence of a Particular gene is Known to be causative of a Particular disease, it is feasible to synthesize a strand of nucleic acid ( DNA, RNA or a similar chemical) That will bind to the messenger RNA (mRNA) produced by That gene and inactivate it, effectively turning that gene...
  9. Gene therapy for epilepsy Gene therapy is being studied for some forms of epilepsy . [1] It relates to viral or non-viral vectors to deliver DNA or RNA to target areas where seizures arise, or to reduce the frequency of seizures . Gene therapy HAS Delivered promising results in early stage clinical trials for other neurological disorders Such As Parkinson’s disease , [2] raising the Hope that it will Become a treatment for intractable epilepsy ....
  10. Mitochondrial replacement therapy Mitochondrial replacement ( MRT , sometimes called mitochondrial donation ) is a special form of in vitro fertilization in which the future baby’s mitochondrial DNA comes from a third party. This technique is used when mothers carry genes for mitochondrial diseases . The two most common techniques in mitochondrial donation are pronuclear transfer and maternal spindle transfer ....

Leave a Comment

Your email address will not be published. Required fields are marked *